-
-
-
-
-
-
-
MERGER ALERT – MFAC, IMMU, and MKGI: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
-
-
-
-
-
-
-
Gilead Sciences (GILD) to Acquire Immunomedics (IMMU) for $21 Billion
-
-
-
-
-
-
-
FDA GRANTS FAST TRACK DESIGNATION TO SACITUZUMAB GOVITECAN FOR NEOADJUVANT/ADJUVANT METASTATIC UROTHELIAL CANCER
-
-
-
-
-
-
-
IMMUNOMEDICS TO HOST CONFERENCE CALL AND WEBCAST ON APRIL 6, 2020 TO PROVIDE CLINICAL AND CORPORATE UPDATE
-
-
-
-
-
-
-
Immunomedics Reports Fourth Quarter and Full Year 2019 Results and Provides Corporate Update
-
-
-
-
-
-
-
Immunomedics Appoints Dr. Loretta Itri Chief Medical Officer
-
-
-
-
-
-
-
Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer
-
913,736 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All